| Earnings (Loss) Per Share |
Earnings (Loss) Per Share The computation of earnings (loss) per share and weighted-average shares of the Company’s Class A common stock outstanding for the periods presented are as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2025 | | 2024 | | 2025 | | 2024 | | Numerator: | | | | | | | | | Net income (loss) attributable to common stockholders – basic | $ | 157,936 | | | $ | 63,822 | | | $ | 124,072 | | | $ | (78,746) | | | Loss (gain) on remeasurement of warrant liabilities | (990) | | | (9,791) | | | (1,483) | | | — | | | Net income (loss) attributable to common stockholders – diluted | $ | 156,946 | | | $ | 54,031 | | | $ | 122,589 | | | $ | (78,746) | | | Denominator: | | | | | | | | | Weighted-average Class A common stock outstanding – basic | 496,517 | | | 479,307 | | | 494,945 | | | 476,788 | | | Weighted-average diluted impact of options and RSUs (1) | 19,578 | | | 25,616 | | | 21,109 | | | — | | | Weighted-average diluted impact of convertible notes (2) | 13,337 | | | 13,337 | | | 13,337 | | | — | | | Weighted-average diluted impact of warrant liabilities (1) | 22 | | | 525 | | | 160 | | | — | | | Weighted-average Class A common stock outstanding – diluted | 529,454 | | | 518,785 | | | 529,551 | | | 476,788 | | | | | | | | | | | Anti-dilutive securities excluded from the calculation of diluted earnings per share | 12,697 | | | 6,308 | | | 10,649 | | | N/A | | Basic earnings per share attributable to common stockholders: | $ | 0.32 | | | $ | 0.13 | | | $ | 0.25 | | | $ | (0.17) | | | Diluted earnings per share attributable to common stockholders: | $ | 0.30 | | | $ | 0.10 | | | $ | 0.23 | | | $ | (0.17) | |
(1) Calculated using the treasury stock method (2) Calculated using if-converted method
There were no preferred or other dividends declared for the three and six months ended June 30, 2025. The below table includes the total securities potentially dilutive for the three and six months ended June 30, 2025 and 2024, which have been excluded from the computation of diluted earnings (loss) per share.
| | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2025 | | 2024 | | 2025 | | 2024 | | Class A common stock resulting from exercise of all warrants | 1,074 | | | — | | | 1,074 | | | 1,441 | | | Stock Options and RSUs | 22,964 | | | 22,107 | | | 20,916 | | | 56,801 | | | Convertible notes | — | | | — | | | — | | | 13,337 | | | Total | 24,038 | | | 22,107 | | | 21,990 | | | 71,579 | |
The Company has contingent consideration arrangements related to business combinations as disclosed in “Note 3 – Business Combinations”. Those potential shares have been excluded from the computations and tables above as they are contingently issuable shares, and the contingency to which the issuance relates was not met at the end of the reporting period.
|